Repository logo
 
Publication

Quality of life and therapeutic regimen management in onychomycosis patients and in vitro study of antiseptic solutions

dc.contributor.authorSilva-Neves, Vasco
dc.contributor.authorHugo, Vitor
dc.contributor.authorAlves, Paulo
dc.contributor.authorAmado, João Costa
dc.contributor.authorPais-Vieira, Carla
dc.contributor.authorSousa, Fátima
dc.contributor.authorCerqueira, Fátima
dc.contributor.authorPinto, Eugénia
dc.contributor.authorPais-Vieira, Miguel
dc.date.accessioned2021-06-27T16:30:42Z
dc.date.available2021-06-27T16:30:42Z
dc.date.issued2021-12
dc.description.abstractOnychomycosis or tinea unguium (EE12.1) and Onychomycosis due to non-dermatophyte moulds (1F2D.5) (OM) is a fungal infection of the nail plates with a high prevalence that often affects vulnerable people with co-existing health problems. Gold standard pharmacological treatments for onychomycosis have been associated with low success rates and increasing antifungal resistance, suggesting that treatment outcome is dependent on multiple variables. Here, the prevalence of OM and quality of life were characterized in two vulnerable populations—Hospital patients and Homeless people. Comparing both groups, the most prevalent fungal species were identified in Hospital patients. Then, the in vitro fungicidal properties of the antiseptics povidone-iodine, polyhexamethylene biguanide-betaine, octenidine dihydrochloride, and a super-oxidized solution against two ATCC strains (Candida albicans and Aspergillus niger) and three clinical fungal isolates from Hospital patients (Candida parapsilosis, Trichophyton interdigitale, and Trichophyton rubrum) were tested. OM prevalence was high in both patient groups studied, who also reported a reduction in quality of life and concerns about the state of their feet. In addition, Hospital patients had a non-negligent therapeutic regimen management style. Antiseptics tested in vitro revealed antifungal properties. As antiseptics are low-cost and easy to apply and have few iatrogenic effects, the demonstration of fungicidal properties of these solutions suggests that they may constitute potential supportive therapeutics for OM.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1038/s41598-021-92111-4pt_PT
dc.identifier.eid85108140906
dc.identifier.issn2045-2322
dc.identifier.pmcPMC8211768
dc.identifier.pmid34140577
dc.identifier.urihttp://hdl.handle.net/10400.14/34012
dc.identifier.wos000664915500015
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleQuality of life and therapeutic regimen management in onychomycosis patients and in vitro study of antiseptic solutionspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue1pt_PT
oaire.citation.titleScientific Reportspt_PT
oaire.citation.volume11pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
32077650.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format